This story was first published in digitalhealth.net

The Brexit Health Alliance has urged Brexit negotiations to ‘put patients first’ following warnings children could miss out on lifesaving clinical trials when the UK leaves the EU.
Brexit threatens the UK’s ability to participate fully in collaborative trials and research activities, including those supporting children and adults with rare and complex diseases, whilst it also risks losing access to crucial EU infrastructure which implements the legislation authorising and managing clinical trials.
The Brexit Health Alliance has highlighted how decision-makers on both sides can mitigate the risks to patient access to medical research, referencing a number of examples exploring the value of UK-EU cooperation on rare diseases, such as a 2013 clinical trial for hemotherapy treatment for children and young adults with recurring neuroblastoma.
The alliance is requesting negotiators to secure a positive future cooperation model for research and innovation between the UK and the EU, which includes UK involvement in EU-funding programmes, as well as a welcoming UK migration system to attract researchers, innovators, and their families.
Niall Dickson, co-chair of the Brexit Health Alliance, said: “We need to make sure UK and EU patients do not lose out as the UK leaves the EU. If patients are to continue to benefit from early access to new and better treatments, health technologies and cutting-edge medicines, we have to be able to take part in multinational research programmes and clinical trials.
“We have achieved so much through cooperation with European partners and this must continue. This can be done if the will is there – what patients need is an agreement which enables maximum cooperation in research and innovation between the EU and the UK, and maximum alignment with the rules regulating medicines and medical devices across Europe. Let’s put patients first - both the UK government and European Commission must make reaching an agreement on future research cooperation a priority.”
This story was first published in digitalhealth.net
UK Building Regulations highlight toxic gas and smoke from layers of paint built up over multiple redecorations as a major cause of permanent ill health or death in a building fire.
Their concern rose with discovery the flame retardant paints most widely used paint along escape routes have been ones which to this day counter-productively use emission of heavy toxic gas to smother flames which rapidly spread along walls if layers of paint delaminate in a fire.
Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients
Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho
Sarah Greenslade, public affairs and communications officer at the British Parking Association looks at some of the problems and innovations in healthcare parking
It’s easy to assume that the comms team is there to handle press enquiries and the occasional social media storm – but the reality is that strategic communications can make a measurable impact across the entire organisation, from operational to financial, when done properly